Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 148.85-129.21-65.6056.89160.58

What is the latest Core EBITDA Growth ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Growth ratio of LASA SUPERGENERICS is 148.85 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024148.85
Mar2023-129.21
Mar2022-65.60
Mar202156.89
Mar2020160.58

How is Core EBITDA Growth of LASA SUPERGENERICS Trending?

Years Core EBITDA Growth % Change
Mar2024 148.85
Positive
Mar2023 -129.21
Negative
Mar2022 -65.6
Negative
Mar2021 56.89
-64.57
Mar2020 160.58 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Growth ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹131.6 Cr -2.2% -9.5% -16.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,400.0 Cr 2% -0.9% 31.9% Stock Analytics
DIVIS LABORATORIES ₹154,622.0 Cr -1.6% -0.4% 57.3% Stock Analytics
CIPLA ₹116,240.0 Cr -0.3% -2.5% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,166.0 Cr -0.5% -3.3% 14% Stock Analytics
ZYDUS LIFESCIENCES ₹98,495.2 Cr -1% 0.6% 39.1% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-2.2%

-9.5%

-16.8%

SENSEX

-0.4%

-2.1%

6.9%


You may also like the below Video Courses